Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis

S. Marais, G. Meintjes, M. Lesosky, K. Wilkinson, R. Wilkinson
{"title":"Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis","authors":"S. Marais, G. Meintjes, M. Lesosky, K. Wilkinson, R. Wilkinson","doi":"10.1097/QAD.0000000000000904","DOIUrl":null,"url":null,"abstract":"Objective:Mycobacterium tuberculosis and Cryptococcus neoformans are major causes of meningitis in HIV-1-infected patients. Identifying differences in the inflammatory profiles of HIV-1-associated tuberculous meningitis (TBM) and cryptococcal meningitis may inform differences in immunopathogenic mechanisms in these diseases. In this study we compared the clinical and inflammatory features of HIV-1-associated TBM, and cryptococcal meningitis. Methods:A prospective study of HIV-1-infected adults who presented with either TBM [antiretroviral therapy (ART)-naive] or cryptococcal meningitis (regardless of ART prescription). Clinical and laboratory findings and concentrations of 40 inflammatory mediators measured in cerebrospinal fluid (CSF, 33 paired with blood) were compared between TBM and cryptococcal meningitis patients regardless of ART prescription and between TBM and cryptococcal meningitis patients not receiving ART. Results:Clinical and laboratory findings were similar in TBM (n=34) and cryptococcal meningitis (n = 19; ART prescribed: n = 10, no ART prescribed: n = 9). Exceptions included a higher median CD4+ cell count [interquartile: 113 (69–199) vs. 25 (8–49) cells/&mgr;l, P = 0.0001] and higher HIV-1 median viral load [plasma: 5.46 (4.82–5.89) vs. 4.87 (4.36–5.17) log10copies/ml, P = 0.037; CSF: 6.05 (5.43–6.56) vs. 5.56 (4.52–5.80) log10copies/ml, P = 0.03] in TBM vs. cryptococcal meningitis patients not receiving ART. CSF interleukin (IL)-17A was lower in TBM compared with cryptococcal meningitis [1.00 (0.25–2.35) vs. 9.31 (1.24–23.36) pg/ml, P-adjusted = 0.03]. Conclusion:Despite presenting with higher peripheral CD4+ cell counts, TBM patients also presented with higher HIV-1 viral loads compared with cryptococcal meningitis patients, suggesting a greater propensity of M. tuberculosis compared with C. neoformans to increase HIV-1 replication in vivo. CSF IL-17A was lower in TBM; its role in the immunopathogenesis of TBM and cryptococcal meningitis deserves further research.","PeriodicalId":355297,"journal":{"name":"AIDS (London, England)","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000000904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 22

Abstract

Objective:Mycobacterium tuberculosis and Cryptococcus neoformans are major causes of meningitis in HIV-1-infected patients. Identifying differences in the inflammatory profiles of HIV-1-associated tuberculous meningitis (TBM) and cryptococcal meningitis may inform differences in immunopathogenic mechanisms in these diseases. In this study we compared the clinical and inflammatory features of HIV-1-associated TBM, and cryptococcal meningitis. Methods:A prospective study of HIV-1-infected adults who presented with either TBM [antiretroviral therapy (ART)-naive] or cryptococcal meningitis (regardless of ART prescription). Clinical and laboratory findings and concentrations of 40 inflammatory mediators measured in cerebrospinal fluid (CSF, 33 paired with blood) were compared between TBM and cryptococcal meningitis patients regardless of ART prescription and between TBM and cryptococcal meningitis patients not receiving ART. Results:Clinical and laboratory findings were similar in TBM (n=34) and cryptococcal meningitis (n = 19; ART prescribed: n = 10, no ART prescribed: n = 9). Exceptions included a higher median CD4+ cell count [interquartile: 113 (69–199) vs. 25 (8–49) cells/&mgr;l, P = 0.0001] and higher HIV-1 median viral load [plasma: 5.46 (4.82–5.89) vs. 4.87 (4.36–5.17) log10copies/ml, P = 0.037; CSF: 6.05 (5.43–6.56) vs. 5.56 (4.52–5.80) log10copies/ml, P = 0.03] in TBM vs. cryptococcal meningitis patients not receiving ART. CSF interleukin (IL)-17A was lower in TBM compared with cryptococcal meningitis [1.00 (0.25–2.35) vs. 9.31 (1.24–23.36) pg/ml, P-adjusted = 0.03]. Conclusion:Despite presenting with higher peripheral CD4+ cell counts, TBM patients also presented with higher HIV-1 viral loads compared with cryptococcal meningitis patients, suggesting a greater propensity of M. tuberculosis compared with C. neoformans to increase HIV-1 replication in vivo. CSF IL-17A was lower in TBM; its role in the immunopathogenesis of TBM and cryptococcal meningitis deserves further research.
白细胞介素-17介导的hiv -1相关结核性和隐球菌性脑膜炎发病机制的差异
目的:结核分枝杆菌和新型隐球菌是hiv -1感染患者发生脑膜炎的主要原因。识别hiv -1相关结核性脑膜炎(TBM)和隐球菌性脑膜炎炎症谱的差异可能为这些疾病免疫致病机制的差异提供信息。在这项研究中,我们比较了hiv -1相关TBM和隐球菌性脑膜炎的临床和炎症特征。方法:对hiv -1感染的成人进行前瞻性研究,这些成人出现TBM[抗逆转录病毒治疗(ART)初期]或隐球菌性脑膜炎(无论ART处方如何)。临床和实验室结果以及脑脊液(CSF, 33与血液配对)中40种炎症介质的浓度在TBM和隐球菌性脑膜炎患者(不考虑ART处方)以及TBM和未接受ART的隐球菌性脑膜炎患者之间进行了比较。结果:TBM (n=34)和隐球菌性脑膜炎(n= 19)的临床和实验室结果相似;ART处方:n = 10,未ART处方:n = 9)。例外情况包括较高的中位数CD4+细胞计数[四分位数间:113(69-199)对25(8-49)个细胞/&mgr; 1, P = 0.0001]和较高的中位数HIV-1病毒载量[血浆:5.46(4.82-5.89)对4.87 (4.36-5.17)log10拷贝/ml, P = 0.037;TBM与未接受抗逆转录病毒治疗的隐球菌脑膜炎患者CSF: 6.05 (5.43-6.56) vs 5.56 (4.52-5.80) log10copies/ml, P = 0.03]。脑脊液白细胞介素(IL)-17A在TBM中较隐球菌性脑膜炎低[1.00(0.25-2.35)比9.31 (1.24-23.36)pg/ml, p校正= 0.03]。结论:尽管TBM患者外周血CD4+细胞计数较高,但与隐球菌性脑膜炎患者相比,TBM患者也表现出更高的HIV-1病毒载量,这表明结核分枝杆菌比新型结核分枝杆菌更倾向于增加体内HIV-1复制。脑脊液IL-17A在TBM中较低;其在TBM和隐球菌性脑膜炎的免疫发病机制中的作用值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信